The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Body composition and immunotherapy outcomes in patients with advanced urothelial carcinoma.
 
Sojin Kim
No Relationships to Disclose
 
Shinkyo Yoon
Honoraria - MSD Oncology
Consulting or Advisory Role - Boryung Pharmaceuticals; Daiichi Sankyo
 
Inkeun Park
Consulting or Advisory Role - Astellas Pharma Korea; Boryung Pharmaceuticals; Chong Kun Dang Pharmaceutical Co; Janssen
Research Funding - Boryung Pharmaceutical Co (Inst); Chong Kun Dang Pharmaceutical Co. (Inst)
 
Jae Lyun Lee
Stock and Other Ownership Interests - Amgen; Black Diamond Therapeutics; Innovent Biologics; Johnson & Johnson/Janssen; Karyopharm Therapeutics; Merck; Zymeworks
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Daiichi Sankyo/Astra Zeneca; Merck; Novartis
Research Funding - Amgen (Inst); Arcus Biosciences (Inst); Arcus Biosciences (Inst); AstraZeneca/MedImmune (Inst); Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Eutilex (Inst); GI Innovation (Inst); Janssen (Inst); LG Chem (Inst); Loxo/Lilly (Inst); Merck KGaA (Inst); MSD (Inst); Novartis (Inst); Oscotec (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Hyehyun Jeong
No Relationships to Disclose
 
Kyung Won Kim
Patents, Royalties, Other Intellectual Property - hold a patent for the AI solution utilized in this study
 
Sun Young Kim
Honoraria - Boryung; LG Chem; Merck
Consulting or Advisory Role - Guardant Health; Ono Pharmaceutical; Roche
Research Funding - Roche/Genentech (Inst)
Expert Testimony - Guardant Health